Question explored with the scientific record
Did the covid vaccine cause female reproductive problems that could effect future offspring?
The evidence does not prove the COVID vaccine causes lasting female reproductive harm or damage to future offspring, but the long-term studies that would settle it do not exist.
The retrieved studies mostly cover pregnancy outcomes, not fertility or germline effects. The largest cohort, 35,691 pregnant mRNA recipients, found miscarriage in 13.9% and preterm birth in 9.4% [7]. A 2022 meta-analysis of 56,428 pregnant women found no significant rise in spontaneous abortion, preterm birth, or low birth weight [7]. A 2025 Korean national study of 8,965 vaccinated versus 8,966 unvaccinated pregnancies found no meaningful difference in preterm birth or congenital malformations [5]. One Israeli cohort of 5,618 deliveries found second-trimester vaccination linked to higher preterm birth risk (adjusted OR 1.49, CI 1.11–2.01) [6]. That signal is real but not replicated.
None of these studies tracked fertility before conception, nor did any follow offspring beyond birth. The menstrual cycle study found only a ~1-day delay in onset [2]. No retrieved record examined germline damage, transgenerational effects, or long-term offspring health. The funding is mostly undeclared or nil [2, 5], but the pregnancy studies are observational, not randomized, and compare vaccinated to unvaccinated, which is the right design.
| Outcome | Vaccinated | Unvaccinated | Finding |
|---|---|---|---|
| Preterm birth (Korean, 2025) | 55.4/1000 | 54.7/1000 | No difference [5] |
| Congenital malformation (Korean) | 76.1/1000 | 77.9/1000 | No difference [5] |
| Preterm birth (Israeli, 2nd trimester) | higher | baseline | OR 1.49 [6] |
| Miscarriage (US, 2021) | 13.9% | not compared | No control group [7] |
The honest answer: short-term pregnancy outcomes look broadly similar, but the question asks about fertility and future offspring. That was never studied. The burden of proof sits with the intervention, and the evidence does not meet it for long-term reproductive or germline safety.
My call: the evidence shows no proven lasting reproductive harm, but the absence of long-term fertility and offspring studies means safety is not established. Confidence: low.
Sources examined 18
-
Impact of Covid 19 Vaccine on Male and Female Fertility
COVID-19 vaccines do not appear to adversely affect fertility in both men and women; the reviewed evidence shows no consistent adverse effects on semen parameters, sex hormones, or pregnancy outcomes, while SARS-CoV-2 infection may transiently perturb reproductive hormones.
DOI: 10.69750/dmls.01.04.043 -
Covid-19 Vaccinations and Menstrual Cycle Alteration
An observational cohort study assessing whether COVID-19 vaccination affects the menstrual cycle, finding a ~1-day delay in the onset of menstruation post-vaccination with no change in total menses days or substantial alteration in cycle length, suggesting minimal clinical impac…
DOI: 10.23880/beba-16000182 -
Covid 19 Pandemic & Women’s Health Pregnancy, Parturition & Postpartum Problems & Vaccination Challenges
This article synthesizes global and Indian evidence on COVID-19 during pregnancy, highlighting higher risks of severe maternal disease, preterm birth and mortality, disruptions to maternal–child health services, and vaccination considerations in pregnancy.
DOI: 10.23880/jqhe-16000262 -
MATERNAL AND FETAL OUTCOME OF PREGNANT PATIENTS GIVEN COVID-19 VACCINATION DURING ANTENATAL PERIOD
A single-center prospective cohort study at Lady Reading Hospital, Peshawar, Pakistan, comparing maternal and fetal outcomes between 60 vaccinated and 60 unvaccinated pregnant women to assess safety of COVID-19 vaccination during pregnancy, finding no significant differences in …
DOI: 10.54112/bcsrj.v2024i1.653 -
Erratum: Correction of Tables in the Article “Maternal Exposures to COVID-19 Vaccine and Adverse Birth Outcomes: National Population Study”
This erratum corrects tables in a national cohort study on maternal exposure to COVID-19 vaccine during pregnancy and reports no meaningful association with preterm birth or congenital malformations after adjustment.
DOI: 10.3346/jkms.2025.40.e198 -
Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study
Vaccination against SARS-CoV-2 during pregnancy is broadly safe with no overall rise in preterm birth or small-for-gestational-age, but second-trimester vaccination may be linked to higher preterm birth risk compared with unvaccinated pregnancies.
DOI: 10.1186/s12884-022-04505-5 -
Efficacy and adverse effects of COVID-19 vaccine in pregnant women
Maternal mRNA COVID-19 vaccination appears generally safe in pregnancy, facilitates transplacental antibody transfer, and is linked to reduced COVID-19–related hospitalization in infants under 6 months, with mostly mild adverse effects.
DOI: 10.56294/saludcyt2022210 -
Side Effects of Covid-19 Vaccination on the Health Status of Pregnant Women
A literature review of five studies on COVID-19 vaccination in pregnant women finds that vaccine side effects are generally similar to those in nonpregnant individuals, vaccination during pregnancy offers protection against COVID-19 with rare obstetric complications, though data…
DOI: 10.24246/johh.vol2.no22023.pp11-22 -
Short-Term Pregnancy Outcomes Following Monoclonal Antibody Treatment for COVID-19 Infection during the Omicron Surge
A small retrospective case series describing short-term outcomes of monoclonal antibody therapy for COVID-19 in 21 pregnant patients during the Omicron surge, noting generally favorable maternal outcomes but notable obstetric complications and a few adverse events.
DOI: 10.23880/whsj-16000167 -
SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
A narrative literature review identifies eight pregnancy-related immune and physiological changes that may increase susceptibility to and severity of SARS-CoV-2 infection, and discusses why the Delta variant has disproportionally affected pregnant women.
DOI: 10.3390/idr13040091 -
Early-onset Cervical Myelitis after COVID-19 Vaccination
This case report describes a 33-year-old woman who developed early-onset cervical myelitis shortly after receiving the BNT162b2 COVID-19 vaccine, highlighting potential immunopathological mechanisms involved in such rare adverse events.
DOI: 10.2169/internalmedicine.2339-23 -
Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease
This study demonstrates that human ACE2 transgenic pigs are susceptible to SARS-CoV-2 infection and develop COVID-19-like disease, providing a valuable large animal model for studying the disease and testing vaccines and therapeutics.
DOI: 10.1038/s41467-024-54615-1 -
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
A comprehensive narrative review examining how chronic HIV infection shapes immune responses to SARS-CoV-2 infection and vaccination, with evidence suggesting possible increased COVID-19 risk in some PLWH while vaccines remain broadly safe and immunogenic, though responses may b…
DOI: 10.1007/s11904-021-00590-x -
Autoantibodies Targeting G-Protein-Coupled Receptors and RAS-Related Molecules in Post-Acute COVID Vaccination Syndrome: A Retrospective Case Series Study
This study presents a retrospective case series of 17 patients who developed post-acute COVID vaccination syndrome (PACVS) characterized by autoantibodies targeting G-protein-coupled receptors and RAS-related molecules, suggesting potential biomarkers for this poorly defined syn…
DOI: 10.3390/biomedicines12122852 -
The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis
This meta-analysis investigates the risk of anaphylactic and anaphylactoid reactions associated with authorized COVID-19 vaccines, revealing significant risks particularly among females aged 18-85 after receiving the BNT162b2 vaccine.
DOI: 10.1186/s12948-022-00167-y -
Prospects for a safe COVID-19 vaccine
Rapid, expert-guided assessment of the potential for immune-enhanced disease in COVID-19 vaccines, synthesizing historical VAED instances, animal data on SARS-CoV-1/MERS-CoV, and emerging human vaccine/convalescent plasma data to conclude that VAED risk for COVID-19 vaccines is …
DOI: 10.1126/scitranslmed.abe0948 -
Causes and costs of global COVID-19 vaccine inequity
This study documents the global inequity in COVID-19 vaccine allocation, identifies the drivers behind it (nationalism, manufacturing capacity, affordability, and delivery logistics), and discusses the resulting health, social, and economic costs along with policy recommendation…
DOI: 10.1007/s00281-023-00998-0 -
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
COVID-19 triggers autoimmune and autoinflammatory processes linked to immune-mediated rheumatic diseases via autoantibodies, thromboinflammation, and complement, with implications for therapy and vaccination.
DOI: 10.47360/1995-4484-2024-32-54